Type
. Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. Journal of medical microbiology. 2006;55(Pt 10):1337-41.
Type
. Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction. Immunopharmacology and immunotoxicology. 2006;28(3):431-41.
Type
. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Seminars in immunology. 2006;18(6):404-10.
Type
. Leprosy. Clinical evidence. 2006;(15):1079-87.
Type
. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scandinavian journal of immunology. 2006;64(4):450-5.
Type
. Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infection and immunity. 2006;74(11):6458-66.
Type
. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS immunology and medical microbiology. 2006;48(1):91-8.
Type
. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. Journal of clinical microbiology [Internet]. 2006;44(9):3154-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1594745/pdf/2250-05.pdf
Type
. [Phacoemulsification with intraocular lens implantation in leprosy patients: case control study]. Arquivos brasileiros de oftalmologia. 2006;69(3):345-8.
Type
. Cranial nerve involvement in patients with leprous neuropathy. Neurology India. 2006;54(3):283-5.